메뉴 건너뛰기




Volumn 62, Issue 2, 2008, Pages 122-124

Preferences of patients receiving bisphosphonates - How to influence the therapeutic adherence

Author keywords

Adherence; Bisphosphonates; Dosing regimen; Once monthly; Osteoporosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

EID: 38949104764     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2007.07.005     Document Type: Article
Times cited : (19)

References (7)
  • 1
    • 33745928735 scopus 로고    scopus 로고
    • A meta-analysis of the association between adherence to drug therapy and mortality
    • Simpson S.H., Eurich D.T., Majumdar S.R., Padwal R.S., Tsuyuki R.T., Varney J., et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 333 7557 (2006) 15
    • (2006) BMJ , vol.333 , Issue.7557 , pp. 15
    • Simpson, S.H.1    Eurich, D.T.2    Majumdar, S.R.3    Padwal, R.S.4    Tsuyuki, R.T.5    Varney, J.6
  • 2
    • 17844396664 scopus 로고    scopus 로고
    • Enhancing adherence in clinical research
    • Robiner W.N. Enhancing adherence in clinical research. Contemp Clin Trials 26 1 (2005) 59-77
    • (2005) Contemp Clin Trials , vol.26 , Issue.1 , pp. 59-77
    • Robiner, W.N.1
  • 3
    • 29144523956 scopus 로고    scopus 로고
    • Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO)
    • Emkey R., Koltun W., Beusterien K., Seidman L., Kivitz A., Devas V., et al. Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO). Curr Med Res Opin 21 12 (2005) 1895-1903
    • (2005) Curr Med Res Opin , vol.21 , Issue.12 , pp. 1895-1903
    • Emkey, R.1    Koltun, W.2    Beusterien, K.3    Seidman, L.4    Kivitz, A.5    Devas, V.6
  • 4
    • 38949156522 scopus 로고    scopus 로고
    • Therapietreue bei der Osteoporosebehandlung
    • Uebelhart D., and Uebelhart B. Therapietreue bei der Osteoporosebehandlung. Ars Medici 25/26 (2005) 1198-1199
    • (2005) Ars Medici , vol.25-26 , pp. 1198-1199
    • Uebelhart, D.1    Uebelhart, B.2
  • 5
    • 33746821808 scopus 로고    scopus 로고
    • Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases
    • Siris E.S., Harris S.T., Rosen C.J., Barr C.E., Arvesen J.N., Abbott T.A., et al. Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc 81 8 (2006) 1013-1022
    • (2006) Mayo Clin Proc , vol.81 , Issue.8 , pp. 1013-1022
    • Siris, E.S.1    Harris, S.T.2    Rosen, C.J.3    Barr, C.E.4    Arvesen, J.N.5    Abbott, T.A.6
  • 6
    • 31744447638 scopus 로고    scopus 로고
    • Adherence and persistence: impact on outcomes and health care resources
    • Reginster J.Y. Adherence and persistence: impact on outcomes and health care resources. Bone 38 2 Suppl. 2 (2006) S18-S21
    • (2006) Bone , vol.38 , Issue.2 SUPPL. 2
    • Reginster, J.Y.1
  • 7
    • 33750588037 scopus 로고    scopus 로고
    • Adherence, persistence, concordance: do we provide optimal management to our patients with osteoporosis?
    • Cortet B., and Benichou O. Adherence, persistence, concordance: do we provide optimal management to our patients with osteoporosis?. Joint Bone Spine 73 5 (2006) e1-e7
    • (2006) Joint Bone Spine , vol.73 , Issue.5
    • Cortet, B.1    Benichou, O.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.